Klue Expands Artificial Intelligence Platform with Offering for Type 1 Diabetes

SAN FRANCISCO — Klue, a digital health company focused on behavior tracking and positive change, announces its platform’s expansion to Type 1 Diabetes (T1D). Klue is already known for its gesture sensing and analytics technology that promotes mindful eating and proper hydration. Now, it is ready to branch out in diabetes.

Leveraging patented technology to create never-seen-before capabilities in the realm of treating T1D, Klue’s software unlocks solutions that will be life-changing for patients who have had a lifetime of daily injections and blood sugar monitoring.